Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.5405
+0.0107 (2.02%)
Oct 28, 2026, 2:40 PM EDT - Market open
Outlook Therapeutics Market Cap
Outlook Therapeutics has a market cap or net worth of $131.58 million as of October 28, 2026. It is the 23,432nd most valuable company in the world and the 3,903rd biggest in the United States. Its market cap has increased by 121.15% in one year.
Market Cap
131.58M
Enterprise Value
138.77M
1-Year Change
121.15%
Global Rank
Country Rank
#3,903 United States
Category
ChartMarket Cap Chart
Since June 14, 2016, Outlook Therapeutics's market cap has increased from $97.40M to $131.58M, an increase of 35.10%. That is a compound annual growth rate of 2.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 131.58M | 29.89% |
| Dec 31, 2025 | 101.30M | 115.07% |
| Dec 31, 2024 | 47.10M | -54.05% |
| Dec 29, 2023 | 102.50M | -58.42% |
| Dec 30, 2022 | 246.50M | -19.18% |
| Dec 31, 2021 | 305.00M | 84.51% |
| Dec 31, 2020 | 165.30M | 828.65% |
| Dec 31, 2019 | 17.80M | -58.12% |
| Dec 31, 2018 | 42.50M | 28.01% |
| Dec 29, 2017 | 33.20M | -53.24% |
| Dec 30, 2016 | 71.00M | -27.10% |
| Jun 14, 2016 | 97.40M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Codexis | 140.17M |
| Innate Pharma | 138.30M |
| Compass Therapeutics | 134.60M |
| TuHURA Biosciences | 134.46M |
| Cue Biopharma | 133.08M |
| Spruce Biosciences | 131.20M |
| Armata Pharmaceuticals | 129.77M |
| Humacyte | 123.98M |